Mr. Song Ruilin, L.L.B. from China University of Political Science and Law, EMBA from China Europe International Business School, Doctor of Social and Administrative Pharmacy, China Pharmaceutical University, is the Executive President of China Pharmaceutical Innovation and Research Development Association (PhIRDA); Executive Deputy Director of the Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University. Mr. Song was former Deputy Director-General of the Department of Education, Science, Culture and Public Health in Legislative Affairs Office at State Council of China. He engaged in health and drug policy and legal studies for a long time, especially in optimizing the reform of drug review and approval system, medical insurance reimbursement system and making policies for pharmaceutical innovation in China.

Currently, Mr. Song also undertakes several social positions, such as Biotech Advisory Panel Member for the Stock Exchange of Hong Kong Limited, Vice President of China Alliance for Rare Disease (CARD), Arbitrator of China International Economic and Trade Arbitration Commission (CIETAC), Standing Director of China Chamber of International Commerce (CCOIC) and Director of Chinese Pharmaceutical Association (CPA).